Erschienen in:
27.07.2018 | Foot and Ankle Trauma (G Moloney, section editor)
The role of biologic in foot and ankle trauma—a review of the literature
verfasst von:
Emily Zhao, Dwayne Carney, Monique Chambers, Samuel Ewalefo, MaCalus Hogan
Erschienen in:
Current Reviews in Musculoskeletal Medicine
|
Ausgabe 3/2018
Einloggen, um Zugang zu erhalten
Abstract
Purpose of review
The use of biologics in orthopedics is becoming increasingly popular as an adjuvant in healing musculoskeletal injuries. Though many biologics involved in the management of foot and ankle injuries are used based on physician preference, reports of improved outcomes when combined with standard operative treatment has led to further clinical interest especially in foot and ankle trauma.
Recent findings
The most recent studies have shown benefits for biologic use in patients predisposed to poor bone and soft tissue healing. Biologics have shown benefit in treating soft tissue injuries such as Achilles ruptures as well as the complications of trauma such as non-unions and osteoarthritis.
Summary
Biologics have shown some benefit in improving functional and pain scores, as well as reducing time to heal in foot and ankle traumatic injuries, with particular success shown with patients that have risk factors for poor healing. As the use of biologics continues to increase, there is a need for high-level studies to confirm early findings of lower level reports.